All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Novo Nordisk A/S revenue reports

Novo Nordisk A/S financial reports, Novo Nordisk A/S annual revenue in 2020. When does Novo Nordisk A/S report revenue?
Add to widgets
Added to widgets

Novo Nordisk A/S total revenue, net income and dynamics of changes in US dollar today

Novo Nordisk A/S current income in US dollar. Net revenue of Novo Nordisk A/S on 31/12/2019 amounted to 32 417 000 000 $. Net income, revenue and dynamics - the main financial indicators of Novo Nordisk A/S. The financial graph of Novo Nordisk A/S shows the values and changes of such indicators: total assets, net income, net revenue. The value of the "total revenue of Novo Nordisk A/S" on the chart is marked in yellow. The value of all Novo Nordisk A/S assets on the graph is shown in green.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019 32 417 000 000 $ +9.03 % ↑ 8 717 000 000 $ +2.59 % ↑
30/09/2019 30 277 000 000 $ +9.06 % ↑ 10 194 000 000 $ +12.8 % ↑
30/06/2019 30 036 000 000 $ +9.59 % ↑ 9 595 000 000 $ -7.232 % ↓
31/03/2019 29 291 000 000 $ +557.86 % ↑ 10 445 000 000 $ +487.62 % ↑
31/12/2018 29 732 000 000 $ - 8 497 000 000 $ -
30/09/2018 27 762 000 000 $ - 9 037 000 000 $ -
30/06/2018 27 407 000 000 $ - 10 343 000 000 $ -
31/03/2018 4 452 471 550 $ - 1 777 516 585 $ -
31/12/2017 4 511 190 720 $ - 1 330 053 480 $ -
30/09/2017 4 199 556 130 $ - 1 541 657 150 $ -
30/06/2017 4 400 085 510 $ - 1 528 921 395 $ -
Show:
to

Novo Nordisk A/S financial report charts

The latest dates of Novo Nordisk A/S financial statements available online: 30/06/2017, 30/09/2019, 31/12/2019. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Novo Nordisk A/S for today is 31/12/2019. Gross profit Novo Nordisk A/S is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Novo Nordisk A/S is 27 514 000 000 $

Novo Nordisk A/S quarterly report dates

Cost of revenue Novo Nordisk A/S is the total cost of producing and distributing of products and services of a company. Cost of revenue Novo Nordisk A/S is 4 903 000 000 $ Total revenue Novo Nordisk A/S refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Novo Nordisk A/S is 32 417 000 000 $ Operating revenue Novo Nordisk A/S is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Novo Nordisk A/S is 32 417 000 000 $

Operating income Novo Nordisk A/S is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Novo Nordisk A/S is 12 852 000 000 $ Net income Novo Nordisk A/S is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Novo Nordisk A/S is 8 717 000 000 $ Current assets Novo Nordisk A/S is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Novo Nordisk A/S is 62 456 000 000 $

31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
27 514 000 000 $ 25 202 000 000 $ 25 187 000 000 $ 24 559 000 000 $ 25 079 000 000 $ 23 347 000 000 $ 23 055 000 000 $ 3 758 560 555 $ 3 753 738 720 $ 3 525 455 890 $ 3 722 664 705 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
4 903 000 000 $ 5 075 000 000 $ 4 849 000 000 $ 4 732 000 000 $ 4 653 000 000 $ 4 415 000 000 $ 4 352 000 000 $ 693 910 995 $ 757 452 000 $ 674 100 240 $ 677 420 805 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
32 417 000 000 $ 30 277 000 000 $ 30 036 000 000 $ 29 291 000 000 $ 29 732 000 000 $ 27 762 000 000 $ 27 407 000 000 $ 4 452 471 550 $ 4 511 190 720 $ 4 199 556 130 $ 4 400 085 510 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
32 417 000 000 $ 30 277 000 000 $ 30 036 000 000 $ 29 291 000 000 $ 29 732 000 000 $ 27 762 000 000 $ 27 407 000 000 $ 4 452 471 550 $ 21 348 865 200 $ 4 199 556 130 $ 4 400 085 510 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
12 852 000 000 $ 12 919 000 000 $ 13 452 000 000 $ 14 239 000 000 $ 10 783 000 000 $ 11 813 000 000 $ 12 204 000 000 $ 2 058 090 080 $ 1 619 174 520 $ 1 900 482 980 $ 2 056 691 970 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
8 717 000 000 $ 10 194 000 000 $ 9 595 000 000 $ 10 445 000 000 $ 8 497 000 000 $ 9 037 000 000 $ 10 343 000 000 $ 1 777 516 585 $ 1 330 053 480 $ 1 541 657 150 $ 1 528 921 395 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 934 000 000 $ 3 601 000 000 $ 3 557 000 000 $ 2 678 000 000 $ 4 544 000 000 $ 3 644 000 000 $ 3 296 000 000 $ 549 077 535 $ 641 900 280 $ 525 141 760 $ 524 544 030 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
19 565 000 000 $ 17 358 000 000 $ 16 584 000 000 $ 15 052 000 000 $ 18 949 000 000 $ 15 949 000 000 $ 15 203 000 000 $ 1 700 470 475 $ 2 134 564 200 $ 1 624 972 910 $ 1 665 972 735 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
62 456 000 000 $ 63 400 000 000 $ 58 720 000 000 $ 52 734 000 000 $ 59 067 000 000 $ 54 135 000 000 $ 57 502 000 000 $ 8 252 696 525 $ 9 682 492 800 $ 9 009 147 730 $ 9 061 060 230 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
125 612 000 000 $ 124 908 000 000 $ 117 909 000 000 $ 110 135 000 000 $ 110 769 000 000 $ 101 895 000 000 $ 103 248 000 000 $ 15 468 411 930 $ 16 495 531 800 $ 15 446 710 345 $ 15 030 322 125 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
15 475 000 000 $ 18 757 000 000 $ 14 457 000 000 $ 9 055 000 000 $ 15 638 000 000 $ 16 401 000 000 $ 18 393 000 000 $ 1 700 470 475 $ 2 765 183 280 $ 2 978 065 035 $ 3 018 202 380 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
58 983 000 000 $ 63 087 000 000 $ 56 595 000 000 $ 54 760 000 000 $ 54 164 000 000 $ 49 425 000 000 $ 49 179 000 000 $ 37 696 380 $ 273 005 040 $ 41 026 700 $ 258 584 535 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - 1 738 166 855 $ 3 038 188 320 $ 3 019 722 915 $ 3 277 247 850 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
68 019 000 000 $ 71 955 000 000 $ 64 824 000 000 $ 62 816 000 000 $ 58 930 000 000 $ 54 383 000 000 $ 54 167 000 000 $ - - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
54.15 % 57.61 % 54.98 % 57.04 % 53.20 % 53.37 % 52.46 % - - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
57 593 000 000 $ 52 953 000 000 $ 53 085 000 000 $ 47 319 000 000 $ 51 839 000 000 $ 47 512 000 000 $ 49 081 000 000 $ 7 314 089 730 $ 8 028 185 400 $ 7 407 844 070 $ 7 441 949 220 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
5 165 000 000 $ 16 688 000 000 $ 15 039 000 000 $ 9 890 000 000 $ 7 412 000 000 $ 11 619 000 000 $ 15 770 000 000 $ 1 622 763 025 $ 972 117 120 $ 2 038 869 195 $ 1 554 426 465 $

Last revenue report of Novo Nordisk A/S was 31/12/2019. According to last financial report total revenue in Novo Nordisk A/S was 32 417 000 000 US dollar and changed by +9.03% since last year. Net income in Novo Nordisk A/S was 8 717 000 000 $ in last quartal, net income changes to +2.59%.

Total assets Novo Nordisk A/S refers to the total amount of assets owned by a person or entity. Total assets Novo Nordisk A/S is 125 612 000 000 $ Current cash Novo Nordisk A/S - the sum of all of the cash a company has on the date of report. Current cash Novo Nordisk A/S is 15 475 000 000 $ Current debt Novo Nordisk A/S is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Novo Nordisk A/S is 58 983 000 000 $

Novo Nordisk A/S stocks data

Novo Nordisk A/S financials